Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

I had the same feeling that it was a positive pr a

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154977
(Total Views: 610)
Posted On: 02/22/2021 10:09:36 PM
Posted By: FortunaFavetFortibus
Re: ombowstring #79383
Quote:
I had the same feeling that it was a positive pr and that CytoDyn might be in discussions with a bigger player - really, can a 20 employee company handle billions of dollars in sales with the partners they now have?



No a 20-ee business cannot handle billions of sales, but we are partnered with American Regents and they are large enough to handle initial distribution. And with any approval, CYDY won't be a 20-ee employer for very long.

I also doubt discussions with a bigger player at this time - first, if they felt they needed that for an approval it should have already been done; and second, nobody is going to pay the value NP and BOD have placed on CYDY, at least not prior to approval.

Quote:
But yet the stock tanked. If they had announced whether or not the trial met the primary endpoint and how many deaths had occurred in each arm and what the p-value was, the market reaction would most likely have been the opposite of what it was. Aside from the above considerations, why wouldn't they release these numbers?



As other posters have pointed out, NP had previously stated he will not publicly release PE data until he has the entire data package. My guess, after several previous PRs with PE data prior to FDA approval, there's likely been prior FDA discussions where this direction was strongly encouraged. Since FDA is judge and jury now, best to play the game the way they "request" it played

And with today's a) overall market down, b) plus strong rotation away from biotech and risk assets, c) plus likely planned short attack, and d) overwhelming percent of ownership by fickle, easily shaken retail investors, it was very easy for the market makers to drive price down and accumulate shares. Assuming what we believe about the molecule's science, the market makers will make themselves nice money today. I'm gonna hold and do the same - just my opinion




(6)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us